Our data suggest that the sensitivity of CLL cells to in vitro spontaneous apoptosis is co-regulated by constitutively activated STAT3 and NF-κB and reflects the in vivo chemo-responsiveness and clinical outcomes. The gene discussed is STAT3; the disease is B-cell chronic lymphocytic leukemia.